Article

Challenges in identifying biomarkers for Smooth muscle tumors of uncertain malignant potential (STUMP)

2022-11-11

Abstract excerpt

Benign uterine leiomyoma (U.LMA) and malignant uterine leiomyosarcoma (U.LMS), which are both uterine mesenchymal tumors, are distinguished by the number of cells with mitotic activity. However, uterine mesenchymal tumors contain tumor cells with various cell morphologies; therefore, making a diagnosis, including differentiation between benign tumors and malignant tumors, is difficult. For example, uterine smooth...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: b72a8ea1-8060-5009-84b2-d7bfad4c0bd1
DOI: 10.32388/bwlkye

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Challenges in identifying biomarkers for Smooth muscle tumors of uncertain malignant potential (STUMP)DOI 10.32388/bwlkyeRead

Potential Life Prognostic Marker for Mesenchymal Tumor Resembling Uterine LeiomyosarcomaSemantic proximity Read

Molecular analyses of 6 different types of uterine smooth muscle tumors: Emphasis in atypical leiomyoma.Semantic proximity Read

Uterine smooth muscle tumor analysis by comparative genomic hybridization: a useful diagnostic tool in challenging lesionsSemantic proximity Read

PHENOTYPIC CHARACTERISTICS OF RELAPSED LEIOMYOMA AND SMOOTH MUSCLE TUMORS OF UNCERTAIN MALIGNANCY POTENTIAL IN REPRODUCTIVE WOMEN.Semantic proximity Read

Is differential expression of p16INK4a based on the classification of uterine smooth muscle tumors associated with a different prognosis? A meta-analysis.Semantic proximity Read

Molecular and Hormonal Determinants of Benign Gynecologic Tumors: A Comparative Study of Uterine Leiomyomas and Ovarian TeratomasSemantic proximity Read

Genomic Profiling Aids Classification of Diagnostically Challenging Uterine Mesenchymal Tumors With Myomelanocytic DifferentiationSemantic proximity Read

Characterization of MED12, HMGA2, and FH alterations reveals molecular variability in uterine smooth muscle tumors.Semantic proximity Read

Recent developments in uterine mesenchymal neoplasms.Semantic proximity Read

Distinct Mechanisms of Benign Tumorigenesis in Young Women: Insights from Uterine Fibroids and Ovarian TeratomasSemantic proximity Read

Molecular differential diagnosis of uterine leiomyomas and leiomyosarcomas.Semantic proximity Read

Prevalence of MED12 mutations in uterine and extrauterine smooth muscle tumours.Semantic proximity Read